This Article Full Text Full Text (PDF) All Versions of this Article: 40/7/2526    most recent STROKEAHA.108.545483v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Liu, W. Articles by Liu, K. J. PubMed PubMed Citation Articles by Liu, W. Articles by Liu, K. J. Related Collections Neuroprotectors Thrombolysis

(Stroke. 2009;40:2526.)
© 2009 American Heart Association, Inc.

Original Contributions

Normobaric Hyperoxia Reduces the Neurovascular Complications Associated With Delayed Tissue Plasminogen Activator Treatment in a Rat Model of Focal Cerebral Ischemia

Wenlan Liu, MD, PhD; Jill Hendren, BS; Xu-Jun Qin, MD, PhD Ke Jian Liu, PhD

From the Department of Pharmaceutical Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM.

Correspondence to Ke Jian Liu, PhD, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131. E-mail kliu{at}salud.unm.edu

Background and Purpose— A major limitation of tissue plasminogen activator (tPA) thrombolysis for ischemic stroke is the narrow time window for safe and effective therapy. Delayed tPA thrombolysis increases the risk of cerebral hemorrhage and mortality, which, in part, is related to neurovascular proteolysis mediated by matrix metalloproteinases (MMPs). We recently showed that normobaric hyperoxia treatment reduces MMP-9 expression and blood–brain barrier disruption in the ischemic brain. Therefore, we hypothesized that normobaric hyperoxia could increase the safety of delayed tPA thrombolysis in stroke.

Methods— Male Sprague-Dawley rats were exposed to normobaric hyperoxia (95% O₂) or normoxia (21% O₂) during 5-hour filament occlusion of the middle cerebral artery followed by 19-hour reperfusion. Thirty minutes before reperfusion, saline or tPA was continuously infused to rats over 1 hour. Outcome parameters were neurological score, mortality rate, brain edema, hemorrhage volume, and MMP-9. Hemorrhage was quantified with a hemoglobin spectrophotometry method. Edema was evaluated as hemispheric enlargement. MMP-9 was measured by gelatin zymography.

Results— In normoxic rats, delayed tPA treatment at 4.5 hours after stroke onset resulted in high mortality, more severe neurological deficits, increased hemorrhage volumes, and augmented MMP-9 induction compared with saline. Rats treated with combined normobaric hyperoxia and tPA showed significantly reduced tPA-associated mortality, brain edema, hemorrhage, and MMP-9 augmentation as compared with tPA alone.

Conclusions— Our results suggest that early normobaric hyperoxia treatment may represent an important strategy to increase the safety of delayed tPA thrombolysis in ischemic stroke.

Key Words: cerebral hemorrhage • tPA • matrix metalloproteinases • oxygen • stroke

This article has been cited by other articles:

				D. I. Hadjiev and P. P. Mineva Normobaric Hyperoxia Treatment in Acute Ischemic Stroke Stroke, November 1, 2009; 40(11): e636 - e636. [Full Text] [PDF]

				W. Liu and K. J. Liu Response to Letter by Hadjiev and Mineva Stroke, November 1, 2009; 40(11): e637 - e637. [Full Text] [PDF]